The FDA has approved perioperative pembrolizumab and enfortumab vedotin for adult patients with muscle-invasive bladder ...

Stephanie Desrosiers discusses strategies for oncology nurses to manage chemotherapy shortages, ensuring patient safety, ...

The US Food and Drug Administration (FDA) has granted approval for zidesamtinib (Jideytro), a next-generation ROS1-selective inhibitor, for the treatment of adult patients with locally advanced or ...

Learn how supportive culture and connection can improve oncology nurse retention and address burnout, shifting focus from individual responsibility. What if the solution to retention is not asking ...

Oncology dietitian Gabrielle Raucci explores the role of creatine in cancer care, highlighting when to use it and risks during active treatment.

Fumiko Chino, MD, discusses strategies for oncology nurses to address unproven treatments like ivermectin while maintaining patient trust. As the oncology landscape continues to grapple with the ...

New research identifies treatment initiation thresholds that impact 3-year metastasis risk in colorectal cancer patients across distinct pathways. For oncology care teams, the coordination of care is ...

A 10-year study of 3,477 patients reveals focal therapy offers high survival and low metastasis for localized prostate cancer with few side effects. A landmark multicenter study published in European ...

NYU Langone experts discuss multidisciplinary care, diagnostic challenges, and nursing's role in treating rare bone and soft tissue sarcomas.

Clinical use cases include AI-assisted palliative-care triage, consolidating EHR signals to surface unmet supportive needs, and ambient listening that drafts notes for nurse verification and workload ...

NYU Langone experts discuss multidisciplinary care, diagnostic challenges, and nursing's role in treating rare bone and soft tissue sarcomas.

NATCO Pharma receives tentative U.S. FDA approval for a generic version of the PARP inhibitor olaparib (Lynparza) for oncology indications. The U.S. Food and Drug Administration (FDA) has granted ...